Glycemic and Economic Outcomes in Elderly Patients with Type 2 Diabetes Initiating Dulaglutide Versus Basal Insulin in a Real-World Setting in the United States: The DISPEL-Advance Study

被引：0
|
作者：
Meredith Hoog
Rosirene Paczkowski
Ahong Huang
Rachel Halpern
Erin Buysman
Sydnie Stackland
Yiran Zhang
Ruth Wangia-Dixon
机构：
[1] Eli Lilly and Company,
[2] GSK,undefined
[3] Tigermed-BDM,undefined
[4] Optum Inc.,undefined
[5] Panalgo,undefined
[6] Elevance Health,undefined
来源：
Diabetes Therapy | 2023年 / 14卷
关键词：
Aged; Diabetes mellitus; Type 2; Retrospective studies; Glycated Hemoglobin; Dulaglutide; Insulin; Glucagon-like peptide-1 receptor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1947 / 1958
页数：11
相关论文
共 50 条
  • [41] Improved Glycemic Control in People with Type 2 Diabetes (T2D) Initiating or Switching to Insulin Degludec/Insulin Aspart (IDegAsp) in a Real-World Setting in China
    Guo, Lixin
    Chen, Liming
    Zhao, Fan
    Liu, Xiao Y.
    Ding, Hongcheng
    Wang, Kun
    Xing, Zhong
    Shankarappa, Vinay Babu
    Chaudhary, Gaurav
    DIABETES, 2024, 73
  • [42] Real-world characteristics of patients with type 2 diabetes on basal insulin initiating add-on GLP-1 analogue therapy
    Dalal, M. R.
    Ling, Z.
    Davis, K. L.
    Meyers, J. L.
    DiGenio, A.
    DIABETOLOGIA, 2012, 55 : S403 - S404
  • [43] Real-World Comparative Effectiveness of Canagliflozin Versus Empagliflozin and Dapagliflozin in Patients with Type 2 Diabetes in the United States
    Lawrence Blonde
    Charmi Patel
    Bingcao Wu
    Yen-Wen Chen
    Christopher D. Pericone
    Brahim Bookhart
    Advances in Therapy, 2021, 38 : 594 - 606
  • [44] Real-World Comparative Effectiveness of Canagliflozin Versus Empagliflozin and Dapagliflozin in Patients with Type 2 Diabetes in the United States
    Blonde, Lawrence
    Patel, Charmi
    Wu, Bingcao
    Chen, Yen-Wen
    Pericone, Christopher D.
    Bookhart, Brahim
    ADVANCES IN THERAPY, 2021, 38 (01) : 594 - 606
  • [45] DOES PEN HELP WHEN ELDERLY PATIENTS WITH TYPE-2 DIABETES INITIATE INSULIN? A REAL-WORLD RETROSPECTIVE STUDY OF INITIATING INSULIN GLARGINE VIA DISPOSABLE PEN VERSUS VIAL
    Miao, R.
    Wei, W.
    Xie, L.
    Baser, O.
    VALUE IN HEALTH, 2012, 15 (04) : A8 - A8
  • [46] The Diabetes Unmet Need with Basal Insulin Evaluation (DUNE) study in type 2 diabetes: Achieving HbA1c targets with basal insulin in a real-world setting
    Meneghini, Luigi F.
    Mauricio, Didac
    Orsi, Emanuela
    Lalic, Nebojsa M.
    Cali, Anna M. G.
    Westerbacka, Jukka
    Stella, Peter
    Candelas, Christophe
    Pilorget, Valerie
    Perfetti, Riccardo
    Khunti, Kamlesh
    DIABETES OBESITY & METABOLISM, 2019, 21 (06): : 1429 - 1436
  • [47] Real-world analysis of percent of patients with type 2 diabetes achieving glycemic goal with insulin glargine
    Misurski, D.
    Schroeder, B.
    Wade, R.
    Quimbo, R.
    Nielsen, L.
    Fabunmi, R.
    Wintle, M.
    VALUE IN HEALTH, 2008, 11 (03) : A18 - A18
  • [48] Improved Clinical Outcomes with Dulaglutide as Add-on Medication to Oral Antidiabetic Drugs with or Without Insulin in Overweight Indian Patients with Type 2 Diabetes Mellitus: Retrospective Study in a Real-World Setting
    Ghosh, Aneesh
    Nair, Rakhee
    CURRENT DIABETES REVIEWS, 2020, 16 (05) : 490 - 496
  • [49] Real-world evidence concerning clinical and economic outcomes of switching to insulin glargine 300 units/mL vs other basal insulins in patients with type 2 diabetes using basal insulin
    Zhou, Fang Liz
    Ye, Fen
    Berhanu, Paulos
    Gupta, Vineet E.
    Gupta, Rishab A.
    Sung, Jennifer
    Westerbacka, Jukka
    Bailey, Timothy S.
    Blonde, Lawrence
    DIABETES OBESITY & METABOLISM, 2018, 20 (05): : 1293 - 1297
  • [50] Much Ado About Nothing? A Real-World Study of Patients with Type 2 Diabetes Switching Basal Insulin Analogs
    Wenhui Wei
    Steve Zhou
    Raymond Miao
    Chunshen Pan
    Lin Xie
    Onur Baser
    Jasvinder Gill
    Advances in Therapy, 2014, 31 : 539 - 560
12345